on-pharmacological interventions for dyspnoea in lung cancer patients

Not Applicable

Completed

• Conditions: ung cancer patients; Lung cancer patients; Cancer - Lung - Non small cell; Public Health - Health promotion/education

• Registration Number: ACTRN12607000087459
• Lead Sponsor: Queensland University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-01-25
• Study Completion: 2011-07-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 144

Inclusion Criteria

Diagnosis: Patients diagnosed with small cell or non-small cell lung cancer; have completed first line therapy for their disease; have an average dyspnoea rating of >2 on 11 point numeric rating scale in the past week; have an aniticipated life expectancy of at least 3 months.

Exclusion Criteria

Demonstrated cognitive impairment that would prevent them from responding to a survey questionniare; have a life expectancy of less than 3 mths.

Study & Design

• Study Type: Interventional
• Study Design: Not specified